In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......
Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria, reports Sohini Das. IMAGE: A woman receives a dose of Covishield at a vaccination centre......
The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in......
The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now,......
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das. IMAGE: Syringes containing the AstraZeneca coronavirus vaccine sit on a metal tray before being......
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......
Close on the heels of the Canadian government warning against the use of Indian herbal remedies, Britain's healthcare agency has said herbal remedies available in the country may contain dangerous......
The six-decade-old pharmaceutical company VHB Life Sciences will come out with an initial public offer in July this year to fund its Rs 400-crore (Rs 4 billion) expansion plans in the near future,......
Law enforcement agents have arrested 237 people worldwide in a 10-day crackdown on fake drugs, resulting in the seizure of counterfeit and unlicensed medicines worth 18.6 million pounds ($31.4......
The company’s revenue from the European market is pegged at around euro 160 million. Of this, UK makes up for euro 110 million, followed by Ireland at euro 30 million and rest from France and......